Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis [Review]

Gharib, M. I. and Burnett, Alan Kenneth 2002. Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis [Review]. European Journal of Heart Failure 4 (3) , pp. 235-242. 10.1016/s1388-9842(01)00201-x

Full text not available from this repository.


Cardiotoxicity is a potential side effect of few chemotherapeutic agents. The anthracycline class of cytotoxic antibiotics are the most famous, but other chemotherapeutic agents can also cause serious cardiotoxicity and are not so well recognised. Examples include cyclophosphamide, ifosfamide, mitomycin and fluorouracil. Prediction and hence prophylaxis has always been a difficult task. Ideal monitoring techniques, upon which efficient prophylaxis depends, are yet to be determined. Current prophylaxis relies upon early detection of systolic and/or diastolic dysfunction. While somewhat useful, in some cases by the time defects are detected progression of chemotherapy-induced cardiomyopathy is beyond prevention. Prophylaxis would be much more efficient if a biochemical marker of myocardiocyte damage could be reliably used to stop further chemotherapy at the correct time before irreversible progressive 'macroscopic' damage becomes evident upon imaging. Work is currently progressing to identify the role of markers such as troponins and natriuretic peptides in this regard.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Uncontrolled Keywords: AntibioticsAntineoplastic/adverseeffects,AntineoplasticAgents/adverse effects*,Antineoplastic Agents Alkylating/adverse effects,Biological Markers,Heart/drug effects*,Heart Diseases/chemically induced*,Heart Diseases/prevention & control,Humans,Risk Factors Substances Antibiotics, Antineoplastic Antineoplastic Agents Antineoplastic Agents, Alkylating Biological Markers
Additional Information: Full Text Sources John Wiley & Sons, Inc. EBSCO Other Literature Sources COS Scholar Universe Medical Heart Diseases - MedlinePlus Health Information
Publisher: Oxford University Press
ISSN: 1388-9842
Last Modified: 25 Jun 2017 04:41

Actions (repository staff only)

Edit Item Edit Item